TCL Archive House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments August 4, 1995
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting. December 7, 2007
TCL Archive In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month August 14, 1992
TCL Archive In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative April 23, 1993
